Microbicides: a new approach to preventing HIV and other sexually transmitted infections
- 1 December 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (12), 977-985
- https://doi.org/10.1038/nrd959
Abstract
Many chemical agents can block human immunodeficiency virus (HIV) infection in the laboratory. Scientists are investigating which of these, used intravaginally by women, will safely prevent the sexual transmission of HIV in humans. Several such products - microbicides - will soon be tested in populations at high risk for HIV, and others are waiting in the wings. Microbicides will provide a low-cost method, controlled by women, for protection against HIV, other sexually transmitted pathogens and unwanted pregnancy, and will therefore have global public-health benefits.Keywords
This publication has 54 references indexed in Scilit:
- WHO/CONRAD Technical Consultation on Nonoxynol-9, World Health Organization, Geneva, 9–10 October 2001: Summary ReportReproductive Health Matters, 2002
- Protection of Cynomolgus Macaque Against Cervicovaginal Transmission of SIVmac251 by the Spermicide Benzalkonium ChlorideJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Vaginal microbicides for the prevention of HIV/AIDS: assessment of the potential marketInternational Journal of Pharmaceutical Medicine, 2000
- Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workersAIDS, 2000
- The Topical Microbicide PRO 2000 Protects against Genital Herpes Infection in a Mouse ModelThe Journal of Infectious Diseases, 1999
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999
- Anti-HIV Type 1 Activity of Sulfated Derivatives of Dextrin against Primary Viral Isolates of HIV Type 1 in Lymphocytes and Monocyte-Derived MacrophagesAIDS Research and Human Retroviruses, 1997
- Recommendations for the development of vaginal microbicidesAIDS, 1996
- INACTIVATION OF HIV BY NONOXYNOL-9The Lancet, 1988
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985